Related Experiment Video
Updated: Mar 15, 2026

06:22
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
3.9K
[Acute respiratory distress syndrome]
Elisa Estenssoro1, Arnaldo Dubin2
1Servicio de Terapia Intensiva, Hospital Interzonal de Agudos General San Martín, Argentina.
Medicina
|August 31, 2016
Summary
Acute respiratory distress syndrome (ARDS) causes severe hypoxemia due to lung inflammation. Protective ventilation and early prone positioning improve survival in ARDS patients.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Respiratory Physiology
Background:
- Acute respiratory distress syndrome (ARDS) is a severe lung injury characterized by inflammatory edema and hypoxemia.
- It results from increased lung capillary permeability, leading to alveolar flooding and intrapulmonary shunting.
- ARDS is often triggered by pneumonia, sepsis, trauma, or aspiration, presenting with characteristic pulmonary infiltrates.
Purpose of the Study:
- To review the pathophysiology, diagnosis, and management of Acute Respiratory Distress Syndrome (ARDS).
- To highlight key therapeutic strategies including mechanical ventilation, prone positioning, and fluid management.
- To discuss adjunctive therapies for severe hypoxemia in ARDS.
Main Methods:
- Review of existing literature on ARDS pathophysiology and treatment.
- Analysis of mechanical ventilation strategies, focusing on protective ventilation and PEEP.
- Evaluation of emerging therapies such as prone positioning and extracorporeal membrane oxygenation (ECMO).
Main Results:
- Protective ventilation (tidal volume 6 ml/kg IBW, plateau pressure <30 cm H2O) is associated with decreased mortality.
- Moderate-to-high PEEP levels are often needed for hypoxemia, but optimal titration remains unclear.
- Early prone positioning in patients with PaO2/FIO2 ≤150 has been linked to increased survival.
Conclusions:
- ARDS management requires addressing the underlying cause and employing lung-protective mechanical ventilation.
- Adjunctive therapies like prone positioning and ECMO may be necessary for severe cases.
- Fluid restriction and careful ventilator management are crucial for improving outcomes in ARDS.
Related Concept Videos
Acute Respiratory Failure-IV
683
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
683
Acute Respiratory Failure-I
1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Acute Respiratory Failure-II
1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Acute Respiratory Failure-III
1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Acute Respiratory Failure-V
617
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
617
Assessment of Respiration
2.2K
The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
2.2K

